Edition:
United States

Erytech Pharma SA (ERYP.OQ)

ERYP.OQ on NASDAQ Stock Exchange Global Select Market

11.10USD
20 Jul 2018
Change (% chg)

$0.30 (+2.78%)
Prev Close
$10.80
Open
$11.10
Day's High
$11.10
Day's Low
$11.10
Volume
102
Avg. Vol
590
52-wk High
$30.48
52-wk Low
$10.35

Chart for

About

Erytech Pharma SA, also known as ERYTECH Pharma, is a France-based biopharmaceutical company developing medicinal products mainly in oncology, hematology and immunology fields of business. The Company offers ESY-ASP (GRASPA), a medicinal product consisting of L-Asparaginase entrapped into human homologous red blood cells. The... (more)

Overall

No Ratios Available.

Financials

  ERYP.OQ Industry Sector
P/E (TTM): -- 217.69 33.34
EPS (TTM): -- -- --
ROI: -- -3.65 13.18
ROE: -- -5.62 15.09

BRIEF-Erytech To Present Results From Phase I Trial Of Eryaspase In All And New Pre Clinical Data At Aacr 2018

* ERYTECH TO PRESENT RESULTS FROM PHASE I TRIAL OF ERYASPASE IN ALL AND NEW PRE-CLINICAL DATA AT AACR 2018 Source text for Eikon: Further company coverage:

Apr 12 2018

BRIEF-Oncodesign Concludes A Partnership With Erytech In Oncology

* ONCODESIGN CONCLUDES A LONG TERM SERVICE-BASED PARTNERSHIP WITH ERYTECH IN ONCOLOGY

Mar 27 2018

BRIEF-Erytech FY Net Loss Widens To 33.5 Million Euros

* REPORTED ON MONDAY FY NET LOSS 33.5 MILLION EUROS, COMPARED TO 21.9 MILLION EUROS IN 2016

Mar 13 2018

Earnings vs. Estimates